Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for ...

Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...

The execs at Haleon, a huge multinational consumer products company, ought to take a good look in the mirror. That is, unless ...

OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...

McConaughey and Woody Harrelson are the attractions in a pair of ads for A.I. booking services. The one involving outdoor ...

Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation ...

Q4 2024 Earnings Call Transcript February 5, 2025 CSG Systems International, Inc. beats earnings expectations. Reported EPS ...

If you think about it, most of these products are cheaper than checking a bag — I hope that's all the justification you need.